A detailed history of Signet Financial Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Signet Financial Management, LLC holds 16,957 shares of BMY stock, worth $978,079. This represents 0.11% of its overall portfolio holdings.

Number of Shares
16,957
Previous 19,399 12.59%
Holding current value
$978,079
Previous $805,000 8.94%
% of portfolio
0.11%
Previous 0.11%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$39.66 - $51.75 $96,849 - $126,373
-2,442 Reduced 12.59%
16,957 $877,000
Q2 2024

Aug 02, 2024

SELL
$40.25 - $52.99 $13,242 - $17,433
-329 Reduced 1.67%
19,399 $805,000
Q1 2024

Apr 15, 2024

BUY
$47.98 - $54.4 $946,549 - $1.07 Million
19,728 New
19,728 $1.07 Million
Q3 2023

Oct 25, 2023

SELL
$57.89 - $64.73 $3,068 - $3,430
-53 Reduced 1.49%
3,502 $203,000
Q2 2023

Jul 18, 2023

BUY
$63.71 - $70.74 $254 - $282
4 Added 0.11%
3,555 $227,000
Q1 2023

Apr 17, 2023

SELL
$65.71 - $74.53 $9,922 - $11,254
-151 Reduced 4.08%
3,551 $246,000
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $5,957 - $7,054
87 Added 2.41%
3,702 $266,000
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $17 - $10,066
-131 Reduced 3.5%
3,615 $257,000
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $7,407 - $8,157
-102 Reduced 2.65%
3,746 $288,000
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $42,298 - $50,719
688 Added 21.77%
3,848 $281,000
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $18,824 - $21,944
-351 Reduced 10.0%
3,160 $197,000
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $207,745 - $243,347
3,511 New
3,511 $208,000
Q2 2021

Aug 09, 2021

SELL
$61.91 - $67.42 $202,817 - $220,867
-3,276 Closed
0 $0
Q1 2021

May 05, 2021

BUY
$59.34 - $66.74 $194,397 - $218,640
3,276 New
3,276 $207,000
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $181,874 - $235,847
-3,730 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $52,540 - $59,262
-952 Reduced 20.33%
3,730 $232,000
Q2 2018

Aug 10, 2018

BUY
$50.53 - $62.98 $129,558 - $161,480
2,564 Added 121.06%
4,682 $259,000
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $96,231 - $110,781
-1,606 Reduced 43.13%
2,118 $134,000
Q4 2017

Feb 13, 2018

SELL
$59.94 - $65.35 $29,850 - $32,544
-498 Reduced 11.8%
3,724 $228,000
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $233,181 - $269,110
4,222
4,222 $269,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Signet Financial Management, LLC Portfolio

Follow Signet Financial Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signet Financial Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signet Financial Management, LLC with notifications on news.